Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent chemoradiotherapy with pemetrexed + cisplatin versus vinorelbine + cisplatin for stage III non-small cell lung cancer
ChiCTR-TRC-09000487Phase 3Completed
- Sponsor
- Shandong Cancer Hospital
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pemetrexed, cisplatin and vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoint: Overall survival. Started Sep 2009; status: completed.
02
Drugs
pemetrexedcisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-09000487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000487.